3096 First-line monotherapy with nivolumab (NIVO) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy, and biomarker analyses

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Gettinger, SN; Hellmann, MD; Shepherd, FA; Antonia, SJ; Brahmer, J; Chow, LQ; Goldman, J; Juergens, R; Borghaei, H; Ready, NE; Gerber, DE; Nathan, F; Shen, Y; Harbison, CT; Rizvi, N

Published Date

  • September 2015

Published In

Volume / Issue

  • 51 /

Start / End Page

  • S632 - S632

Published By

International Standard Serial Number (ISSN)

  • 0959-8049

Digital Object Identifier (DOI)

  • 10.1016/s0959-8049(16)31737-3